Learn More
Medchemexpress LLC 5-amino-3-(4-phenoxyphenyl)-1-[(3r)-1-prop-2-enoylpiperidin-3-yl]pyrazole-4-carboxamide | 1558036-85-3 | MFCD31382019 | 99.6% | 431.49 | C24H25N5O3 | 50 MG

Supplier: Medchemexpress LLC HY10176650MG
Btk inhibitor 2 (BGB-3111 analog) is a small-molecule Bruton's tyrosine kinase (BTK) inhibitor described in patent US 20170224688 A1. Supplied for research use only, the compound is characterized by high purity and a molecular weight of 431.49 g/mol. It is offered as a solid powder and as a 10 mM solution in DMSO, and includes batch-specific certificate of analysis.
- High purity suitable for research applications (reported 99.57%).
- Molecular weight 431.49 g/mol.
- Available as solid and as 10 mM solution in DMSO.
- Provided with batch-specific certificate of analysis.
- Intended for in vitro and preclinical research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.